Structure – ADME relationship: still a long way to go?

Bibliography

• Hou TJ, Xu XJ. Recent development and application of virtual screening in drug discovery: An overview. Curr Pharm Des 2004;10:1011-33
   PubMed Web of Science ®Google Scholar
• Segall MD, Beresford AP, Gola JMR, et al. Focus on success: using a probabilistic approach to achieve an optimal balance of compound properties in drug discovery. Expert Opin Drug Metab 2006;2:325-37
   PubMed Web of Science ®Google Scholar
• Beresford AP, Selick HE, Tarbit MH. The emerging importance of predictive ADME simulation in drug discovery. Drug Discov Today 2002;7:109-16
   PubMed Web of Science ®Google Scholar
• Kennedy T. Managing the drug discovery/development interface. Drug Discov Today 1997;2:436-44
   Web of Science ®Google Scholar
• Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 2004;3:711-5
   PubMed Web of Science ®Google Scholar
• Li AP. Screening for human ADME/Tox drug properties in drug discovery. Drug Discov Today 2001;6:357-66
   PubMed Web of Science ®Google Scholar
• Bevan CD, Lloyd RS. A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. Anal Chem 2000;72:1781-7
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3-25
   Web of Science ®Google Scholar
• Wienkers LC, Heath TG. Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov 2005;4:825-33
   PubMed Web of Science ®Google Scholar
• Crespi CL, Miller VP, Penman BW. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal Biochem 1997;248:188-90
   PubMed Web of Science ®Google Scholar
• Cohen LH, Remley MJ, Raunig D, et al. In vitro drug interactions of cytochrome P450: An evaluation of fluorogenic to conventional substrates. Drug Metab Dispos 2003;31:1005-15
   PubMed Web of Science ®Google Scholar
• van de Waterbeemd H, Gifford E. ADMET in silico modelling: Towards prediction paradise? Nat Rev Drug Discov 2003;2:192-204
   PubMed Web of Science ®Google Scholar
• Delaney JS. Predicting aqueous solubility from structure. Drug Discov Today 2005;10:289-95
   PubMed Web of Science ®Google Scholar
• Johnson SR, Zheng WF. Recent progress in the computational prediction of aqueous solubility and absorption. AAPS J 2006;8:E27-40
   PubMed Web of Science ®Google Scholar
• Norinder U, Bergstrom CAS. Prediction of ADMET properties. ChemMedChem 2006;1:920-37
   PubMed Web of Science ®Google Scholar
• Hou TJ, Wang JM, Zhang W, et al. Recent advances in computational prediction of drug absorption and permeability in drug discovery. Curr Med Chem 2006;13:2653-67
   PubMed Web of Science ®Google Scholar
• Hou TJ, Li YY, Zhang W, et al. Recent developments of in silico predictions of intestinal absorption and oral bioavailability. Comb Chem High Throughput Screen 2008; In press
   Google Scholar
• Fagerholm U. Prediction of human pharmacokinetics: gastrointestinal absorption. J Pharm Pharmacol 2007;59:905-16
   PubMed Web of Science ®Google Scholar
• Norinder U, Haeberlein M. Computational approaches to the prediction of the blood-brain distribution. Adv Drug Deliv Rev 2002;54:291-313
   PubMed Web of Science ®Google Scholar
• Ekins S, Ecker GF, Chiba P, et al. Future directions for drug transporter modelling. Xenobiotica 2007;37:1152-70
   PubMed Web of Science ®Google Scholar
• Jolivette LJ, Ekins S. Methods for predicting human drug metabolism. Adv Clin Chem 2007;43:131-76
   PubMed Web of Science ®Google Scholar
• Gola J, Obrezanova O, Champness E, et al. ADMET property prediction: The state of the art and current challenges. Qsar Comb Sci 2006;25:1172-80
   Google Scholar
• Parrott N, Paquereau N, Coassolo P, et al. An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discovery. J Pharm Sci 2005;94:2327-43
   PubMed Web of Science ®Google Scholar
• Hou TJ, Xia K, Zhang W, et al. ADME evaluation in drug discovery. 4. Prediction of aqueous solubility based on atom contribution approach. J Chem Inf Comp Sci 2004;44:266-75
   PubMedGoogle Scholar
• Jorgensen WL, Duffy EM. Prediction of drug solubility from structure. Adv Drug Deliv Rev 2002;54:355-66
   PubMed Web of Science ®Google Scholar
• Available from: www.fda.gov/cder/OPS/BCS_guidance.htm
   Google Scholar
• Fagerholm U. Evaluation and suggested improvements of the Biopharmaceutics Classification System (BCS). J Pharm Pharmacol 2007;59:751-7
   PubMed Web of Science ®Google Scholar
• Yazdanian M, Briggs K, Jankovsky C, et al. The ‘high solubility’ definition of the current FDA Guidance on Biopharmaceutical Classification System may be too strict for acidic drugs. Pharm Res 2004;21:293-9
   PubMed Web of Science ®Google Scholar
• Yalkowsky SH, Valvani SC. Solubility and partitioning.1. Solubility of non-electrolytes in water. J Pharm Sci 1980;69:912-22
   PubMed Web of Science ®Google Scholar
• Jain N, Yalkowsky SH. Estimation of the aqueous solubility I: Application to organic nonelectrolytes. J Pharm Sci 2001;90:234-52
   PubMed Web of Science ®Google Scholar
• Huuskonen J, Salo M, Taskinen J. Aqueous solubility prediction of drugs based on molecular topology and neural network modeling. J Chem Inf Comp Sci 1998;38:450-6
   PubMedGoogle Scholar
• Abraham MH, Le J. The correlation and prediction of the solubility of compounds in water using an amended solvation energy relationship. J Pharm Sci 1999;88:868-80
   PubMed Web of Science ®Google Scholar
• Jorgensen WL, Duffy EM. Prediction of drug solubility from Monte Carlo simulations. Bioorg Med Chem Lett 2000;10:1155-8
   PubMed Web of Science ®Google Scholar
• McElroy NR, Jurs PC. Prediction of aqueous solubility of heteroatom-containing organic compounds from molecular structure. J Chem Inf Comp Sci 2001;41:1237-47
   PubMedGoogle Scholar
• McFarland JW, Avdeef A, Berger CM, et al. Estimating the water solubilities of crystalline compounds from their chemical structures alone. J Chem Inf Comp Sci 2001;41:1355-9
   PubMedGoogle Scholar
• Liu RF, Sun HM, So SS. Development of quantitative structure-property relationship models for early ADME evaluation in drug discovery. 2. Blood-brain barrier penetration. J Chem Inf Comp Sci 2001;41:1623-32
   PubMedGoogle Scholar
• Tetko IV, Tanchuk VY, Kasheva TN, et al. Estimation of aqueous solubility of chemical compounds using E-state indices. J Chem Inf Comp Sci 2001;41:1488-93
   PubMedGoogle Scholar
• Engkvist O, Wrede P. High-throughput, in silico prediction of aqueous solubility based on one- and two-dimensional descriptors. J Chem Inf Comp Sci 2002;42:1247-9
   PubMedGoogle Scholar
• Yan AX, Gasteiger J. Prediction of aqueous solubility of organic compounds based on a 3D structure representation. J Chem Inf Comp Sci 2003;43:429-34
   PubMedGoogle Scholar
• Butina D, Gola JMR. Modeling aqueous solubility. J Chem Inf Comp Sci 2003;43:837-41
   PubMedGoogle Scholar
• Goller AH, Hennemann M, Keldenich J, et al. In silico prediction of buffer solubility based on quantum-mechanical and HQSAR- and topology-based descriptors. J Chem Inf Model 2006;46:648-58
   PubMed Web of Science ®Google Scholar
• Huuskonen J. Estimation of aqueous solubility for a diverse set of organic compounds based on molecular topology. J Chem Inf Comp Sci 2000;40:773-7
   PubMedGoogle Scholar
• Nirmalakhandan NN, Speece RE. Prediction of aqueous solubility of organic chemicals based on molecular structure. 2. Application to Pnas, Pcbs, Pcdds, etc. Environ Sci Technol 1989;23:708-13
   Web of Science ®Google Scholar
• Suzuki T. Development of an automatic estimation system for both the partition-coefficient and aqueous solubility. J Comput Aid Mol Des 1991;5:149-66
   PubMed Web of Science ®Google Scholar
• Klopman G, Wang S, Balthasar DM. Estimation of aqueous solubility of organic molecules by the group contribution approach: application to the study of biodegradation. J Chem Inf Comp Sci 1992;32:474-82
   PubMedGoogle Scholar
• Klopman G, Zhu H. Estimation of the aqueous solubility of organic molecules by the group contribution approach. J Chem Inf Comp Sci 2001;41:439-45
   PubMedGoogle Scholar
• Wang JM, Krudy G, Hou TJ, et al. Development of reliable aqueous solubility models and their application in druglike analysis. J Chem Inf Model 2007;47:1395-404
   PubMed Web of Science ®Google Scholar
• Kühne R, Ebert RU, Schuurmann G. Model selection based on structural similarity - Method description and application to water solubility prediction. J Chem Inf Model 2006;46:636-41
   PubMed Web of Science ®Google Scholar
• Meylan WM, Howard PH. Estimating log P with atom/fragments and water solubility with log P. Perspect Drug Discov 2000;19:67-84
   Web of Science ®Google Scholar
• Marrero J, Gani R. Group-contribution-based estimation of octanol/water partition coefficient and aqueous solubility. Ind Eng Chem Res 2002;41:6623-33
   Web of Science ®Google Scholar
• Huuskonen J. Estimation of water solubility from atom-type electrotopological state indices. Environ Toxicol Chem 2001;20:491-7
   PubMed Web of Science ®Google Scholar
• van de Waterbeemd H, Kansy M. Hydrogen-bonding capacity and brain penetration. Chimia 1992;46:299-303
   Web of Science ®Google Scholar
• Palm K, Stenberg P, Luthman K, et al. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm Res 1997;14:568-71
   PubMed Web of Science ®Google Scholar
• Grass GM, Sinko PJ. Effect of diverse datasets on the predictive capability of ADME models in drug discovery. Drug Discov Today 2001;6:S54-61
   PubMed Web of Science ®Google Scholar
• Hou TJ, Wang JM, Zhang W, et al. ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification. J Chem Inf Model 2007;47:208-18
   PubMed Web of Science ®Google Scholar
• Hou TJ, Wang JM, Li YY. ADME evaluation in drug discovery. 8. The prediction of human intestinal absorption by a support vector machine. J Chem Inf Model 2007;47:2408-15
   PubMed Web of Science ®Google Scholar
• Zhao YH, Le J, Abraham MH, et al. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. J Pharm Sci 2001;90:749-84
   PubMed Web of Science ®Google Scholar
• Cruciani C, Crivori P, Carrupt PA, et al. Molecular fields in quantitative structure-permeation relationships: the VolSurf approach. J Mol Struc Theochem 2000;503:17-30
   Web of Science ®Google Scholar
• Norinder U, Osterberg T, Artursson P. Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics. Eur J Pharm Sci 1999;8:49-56
   PubMed Web of Science ®Google Scholar
• Andrews CW, Bennett L, Yu LX. Predicting human oral bioavailability of a compound: Development of a novel quantitative structure–bioavailability relationship. Pharm Res 2000;17:639-44
   PubMed Web of Science ®Google Scholar
• Wang JM, Krudy G, Xie XQ, et al. Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion. J Chem Inf Model 2006;46:2674-83
   PubMed Web of Science ®Google Scholar
• Yoshida F, Topliss JG. QSAR model for drug human oral bioavailability. J Med Chem 2000;43:2575-85
   PubMed Web of Science ®Google Scholar
• Turner JV, Glass BD, Agatonovic-Kustrin S. Prediction of drug bioavailability based on molecular structure. Anal Chim Acta 2003;485:89-102
   Web of Science ®Google Scholar
• Hou TJ, Wang JM, Zhang W, et al. ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules? J Chem Inf Model 2007;47:460-3
   PubMed Web of Science ®Google Scholar
• Veber DF, Johnson SR, Cheng HY, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002;45:2615-23
   PubMed Web of Science ®Google Scholar
• Hansen NT, Kouskoumvekaki I, Jorgensen FS, et al. Prediction of pH-dependent aqueous solubility of druglike molecules. J Chem Inf Model 2006;46:2601-9
   PubMed Web of Science ®Google Scholar
• Available from: www.bio-rad.com
   Google Scholar
• Abshear T, Banik GM, D'Souza ML, et al. A model validation and consensus building environment. Sar Qsar Environ Res 2006;17:311-21
   PubMed Web of Science ®Google Scholar
• Stouch TR, Kenyon JR, Johnson SR, et al. In silico ADME/Tox: why models fail. J Comput Aid Mol Des 2003;17:83-92
   PubMed Web of Science ®Google Scholar